Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin in Active Crohn's Disease
NCT00269386Phase 3Completed
- Sponsor
- Royal Liverpool University Hospital
- Start
- Apr 2000
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Clarithromycin with Placebo (2 arms). Primary endpoint: Remission (CDAI < 150) and Response (Fall in CDAI > 70) at 2 months. Started Apr 2000; status: completed.
02
Drugs
clarithromycin
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00269386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269386.